SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-24-018059
Filing Date
2024-06-06
Accepted
2024-06-06 08:05:39
Documents
50
Period of Report
2024-06-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-060624.htm   iXBRL 8-K 31441
2 PRESS RELEASE ex99-01.htm EX-99.01 20275
3 COMBINED BLOCKADE OF THE CD154 AND CD28 CO-STIMULATION PATHWAYS ATTENUATES PATHO ex99-02.htm EX-99.02 16356
4 EXTENDED SURVIVAL OF 9- AND 10-GENE-EDITED PIG HEART XENOGRAFTS WITH ISCHEMIA MI ex99-03.htm EX-99.03 16991
5 EXPERIENCE WITH A NOVEL DELAYED IMMUNE TOLERANCE PROTOCOL IN NONHUMAN PRIMATES B ex99-04.htm EX-99.4 5239
9 GRAPHIC ex99-02_img01.jpg GRAPHIC 214697
10 GRAPHIC ex99-02_img02.jpg GRAPHIC 160926
11 GRAPHIC ex99-02_img03.jpg GRAPHIC 119469
12 GRAPHIC ex99-02_img04.jpg GRAPHIC 134847
13 GRAPHIC ex99-02_img05.jpg GRAPHIC 111688
14 GRAPHIC ex99-02_img06.jpg GRAPHIC 140208
15 GRAPHIC ex99-02_img07.jpg GRAPHIC 154564
16 GRAPHIC ex99-02_img08.jpg GRAPHIC 115188
17 GRAPHIC ex99-02_img09.jpg GRAPHIC 92345
18 GRAPHIC ex99-02_img10.jpg GRAPHIC 109335
19 GRAPHIC ex99-02_img11.jpg GRAPHIC 104256
20 GRAPHIC ex99-02_img12.jpg GRAPHIC 107936
21 GRAPHIC ex99-02_img13.jpg GRAPHIC 106583
22 GRAPHIC ex99-02_img14.jpg GRAPHIC 145755
23 GRAPHIC ex99-03_img01.jpg GRAPHIC 109489
24 GRAPHIC ex99-03_img02.jpg GRAPHIC 171619
25 GRAPHIC ex99-03_img03.jpg GRAPHIC 105040
26 GRAPHIC ex99-03_img04.jpg GRAPHIC 162155
27 GRAPHIC ex99-03_img05.jpg GRAPHIC 150436
28 GRAPHIC ex99-03_img06.jpg GRAPHIC 164217
29 GRAPHIC ex99-03_img07.jpg GRAPHIC 164379
30 GRAPHIC ex99-03_img08.jpg GRAPHIC 87057
31 GRAPHIC ex99-03_img09.jpg GRAPHIC 183165
32 GRAPHIC ex99-03_img10.jpg GRAPHIC 156077
33 GRAPHIC ex99-03_img11.jpg GRAPHIC 129339
34 GRAPHIC ex99-03_img12.jpg GRAPHIC 123629
35 GRAPHIC ex99-03_img13.jpg GRAPHIC 120763
36 GRAPHIC ex99-03_img14.jpg GRAPHIC 173102
37 GRAPHIC ex99-03_img15.jpg GRAPHIC 176797
38 GRAPHIC ex99-03_img16.jpg GRAPHIC 153483
39 GRAPHIC ex99-03_img17.jpg GRAPHIC 125100
40 GRAPHIC ex99-03_img18.jpg GRAPHIC 179835
41 GRAPHIC ex99-04_img01.jpg GRAPHIC 790308
  Complete submission text file 0001839882-24-018059.txt   7508916

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20240606.xsd EX-101.SCH 3024
7 XBRL LABEL FILE tnxp-20240606_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE tnxp-20240606_pre.xml EX-101.PRE 22365
53 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-060624_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241023879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)